Aberdeen Group plc reduced its stake in Vertex Pharmaceuticals by 16.8%, now holding 262,057 shares valued at $118.81 million. This move indicates changing investor sentiment towards the biotech firm.

NodeGuardian

2026-04-17 07:14:25

Abstract generation in progress

Aberdeen Group plc, a major institutional investor, decreased its stake in Vertex Pharmaceuticals (NASDAQ:VRTX) by 16.8% during the fourth quarter of 2025. The firm’s 13F filing shows it now holds 262,057 shares worth $118.81 million. This reduction suggests a potential shift in investor sentiment regarding the biotech company, which focuses on treatments for serious diseases like cystic fibrosis.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
185.49K Popularity
#
Gate13thAnniversaryLive
735.07K Popularity
#
AltcoinsRallyStrong
7.31M Popularity
#
AnthropicvsOpenAIHeatsUp
1.06M Popularity
#
KalshiFacesNevadaRegulatoryClash
455.82K Popularity

Sitemap

Aberdeen Group Reduces Stake in Vertex Pharmaceuticals

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

AltcoinsRallyStrong

AnthropicvsOpenAIHeatsUp

KalshiFacesNevadaRegulatoryClash

Pin